U.S. Rep. Nick Langworthy Introduces Bipartisan Bill to Lower Prescription Drug Costs
U.S. Representative Nick Langworthy has introduced bipartisan legislation, the Biosimilars Access and Affordability Act, aimed at making prescription drugs more affordable. This bill focuses on facilitating the access of lower-cost alternatives, known as biosimilars, to patients through Medicare. Biosimilars are designed to be more affordable versions of existing expensive medications, offering additional treatment choices. The legislation seeks to ensure that if a biosimilar is progressing through the FDA approval process, it should have a fair chance to compete in the market. Conversely, it also aims to prevent Medicare from waiting indefinitely if a promised competition does not materialize. According to Langworthy, competition is a powerful tool for driving innovation and affordability in the healthcare system, and expanding access to biosimilars could significantly reduce prescription drug costs for millions of patients. The bill has garnered bipartisan support, with co-sponsors from both sides of the...